Impact of SPARC expression on pembrolizumab treatment response and prognostic role in advanced stage non-small cell lung cancer
| dc.authorid | 0000-0002-0077-6971 | |
| dc.authorid | 0000-0002-0443-6966 | |
| dc.authorid | 0000-0001-7934-7039 | |
| dc.authorid | 0000-0001-8802-6376 | |
| dc.contributor.author | Göktaş Aydın, Sabin | |
| dc.contributor.author | Bilici, Ahmet | |
| dc.contributor.author | Çalış, Elif | |
| dc.contributor.author | Ölmez, Ömer Fatih | |
| dc.contributor.author | Karcı, Ebru | |
| dc.date.accessioned | 2024-01-24T09:30:43Z | |
| dc.date.available | 2024-01-24T09:30:43Z | |
| dc.date.issued | 2023 | |
| dc.department | İstanbul Medipol Üniversitesi, Tıp Fakültesi, Cerrahi Tıp Bilimleri Bölümü, Tıbbi Patoloji Ana Bilim Dalı | |
| dc.department | İstanbul Medipol Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, İç Hastalıkları Ana Bilim Dalı | |
| dc.description.abstract | [Abstract Not Available] | |
| dc.identifier.citation | Göktaş Aydın, S., Bilici, A., Çalış, E., Ölmez, Ö. F. ve Karcı, E. (2023). Impact of SPARC expression on pembrolizumab treatment response and prognostic role in advanced stage non-small cell lung cancer. Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO). Chicago, IL, 02-06 June 2023. | |
| dc.identifier.issn | 0732-183X | |
| dc.identifier.issn | 1527-7755 | |
| dc.identifier.issue | 16 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12511/12194 | |
| dc.identifier.volume | 41 | |
| dc.identifier.wos | 001053772004799 | en_US |
| dc.identifier.wosquality | Q1 | |
| dc.indekslendigikaynak | Web of Science | |
| dc.institutionauthor | Göktaş Aydın, Sabin | |
| dc.institutionauthor | Bilici, Ahmet | |
| dc.institutionauthor | Çalış, Elif | |
| dc.institutionauthor | Ölmez, Ömer Fatih | |
| dc.institutionauthor | Karcı, Ebru | |
| dc.language.iso | en | |
| dc.publisher | Lippincott Williams & Wilkins | |
| dc.relation.ispartof | Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) | en_US |
| dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | |
| dc.rights | info:eu-repo/semantics/closedAccess | |
| dc.subject | Cell Lung Cancer | |
| dc.subject | SPARC | |
| dc.subject | Pembrolizumab Treatment | |
| dc.title | Impact of SPARC expression on pembrolizumab treatment response and prognostic role in advanced stage non-small cell lung cancer | |
| dc.type | Conference Object |
Dosyalar
Lisans paketi
1 - 1 / 1
Küçük Resim Yok
- İsim:
- license.txt
- Boyut:
- 1.44 KB
- Biçim:
- Item-specific license agreed upon to submission
- Açıklama:











